IBDEI0WR ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,14765,1,3,0)
;;=3^Hemiplegia after Unsp Crbvasc Dis,Right Dominant Side
;;^UTILITY(U,$J,358.3,14765,1,4,0)
;;=4^I69.951
;;^UTILITY(U,$J,358.3,14765,2)
;;=^5007561
;;^UTILITY(U,$J,358.3,14766,0)
;;=I69.953^^58^707^21
;;^UTILITY(U,$J,358.3,14766,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14766,1,3,0)
;;=3^Hemiplegia after Unsp Crbvasc Dis,Right Nondominant Side
;;^UTILITY(U,$J,358.3,14766,1,4,0)
;;=4^I69.953
;;^UTILITY(U,$J,358.3,14766,2)
;;=^5007562
;;^UTILITY(U,$J,358.3,14767,0)
;;=G81.92^^58^707^22
;;^UTILITY(U,$J,358.3,14767,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14767,1,3,0)
;;=3^Hemiplegia,Unspec Affecting Left Dominant Side
;;^UTILITY(U,$J,358.3,14767,1,4,0)
;;=4^G81.92
;;^UTILITY(U,$J,358.3,14767,2)
;;=^5004122
;;^UTILITY(U,$J,358.3,14768,0)
;;=G81.94^^58^707^23
;;^UTILITY(U,$J,358.3,14768,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14768,1,3,0)
;;=3^Hemiplegia,Unspec Affecting Left Nondominant Side
;;^UTILITY(U,$J,358.3,14768,1,4,0)
;;=4^G81.94
;;^UTILITY(U,$J,358.3,14768,2)
;;=^5004124
;;^UTILITY(U,$J,358.3,14769,0)
;;=G81.91^^58^707^24
;;^UTILITY(U,$J,358.3,14769,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14769,1,3,0)
;;=3^Hemiplegia,Unspec Affecting Right Dominant Side
;;^UTILITY(U,$J,358.3,14769,1,4,0)
;;=4^G81.91
;;^UTILITY(U,$J,358.3,14769,2)
;;=^5004121
;;^UTILITY(U,$J,358.3,14770,0)
;;=G81.93^^58^707^25
;;^UTILITY(U,$J,358.3,14770,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14770,1,3,0)
;;=3^Hemiplegia,Unspec Affecting Right Nondominant Side
;;^UTILITY(U,$J,358.3,14770,1,4,0)
;;=4^G81.93
;;^UTILITY(U,$J,358.3,14770,2)
;;=^5004123
;;^UTILITY(U,$J,358.3,14771,0)
;;=I69.942^^58^707^42
;;^UTILITY(U,$J,358.3,14771,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14771,1,3,0)
;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Dominant Side
;;^UTILITY(U,$J,358.3,14771,1,4,0)
;;=4^I69.942
;;^UTILITY(U,$J,358.3,14771,2)
;;=^5133582
;;^UTILITY(U,$J,358.3,14772,0)
;;=I69.944^^58^707^43
;;^UTILITY(U,$J,358.3,14772,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14772,1,3,0)
;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Nondominant Side
;;^UTILITY(U,$J,358.3,14772,1,4,0)
;;=4^I69.944
;;^UTILITY(U,$J,358.3,14772,2)
;;=^5133585
;;^UTILITY(U,$J,358.3,14773,0)
;;=I69.941^^58^707^44
;;^UTILITY(U,$J,358.3,14773,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14773,1,3,0)
;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Dominant Side
;;^UTILITY(U,$J,358.3,14773,1,4,0)
;;=4^I69.941
;;^UTILITY(U,$J,358.3,14773,2)
;;=^5133581
;;^UTILITY(U,$J,358.3,14774,0)
;;=I69.943^^58^707^45
;;^UTILITY(U,$J,358.3,14774,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14774,1,3,0)
;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Nondominant Side
;;^UTILITY(U,$J,358.3,14774,1,4,0)
;;=4^I69.943
;;^UTILITY(U,$J,358.3,14774,2)
;;=^5133584
;;^UTILITY(U,$J,358.3,14775,0)
;;=G35.^^58^707^46
;;^UTILITY(U,$J,358.3,14775,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14775,1,3,0)
;;=3^Multiple sclerosis
;;^UTILITY(U,$J,358.3,14775,1,4,0)
;;=4^G35.
;;^UTILITY(U,$J,358.3,14775,2)
;;=^79761
;;^UTILITY(U,$J,358.3,14776,0)
;;=G20.^^58^707^47
;;^UTILITY(U,$J,358.3,14776,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,14776,1,3,0)
;;=3^Parkinson's disease
;;^UTILITY(U,$J,358.3,14776,1,4,0)
;;=4^G20.
;;^UTILITY(U,$J,358.3,14776,2)
;;=^5003770
;;^UTILITY(U,$J,358.3,14777,0)
;;=R56.9^^58^707^6
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0WR 3791 printed Sep 23, 2025@19:33:16 Page 2
IBDEI0WR ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,14765,1,3,0)
+2 ;;=3^Hemiplegia after Unsp Crbvasc Dis,Right Dominant Side
+3 ;;^UTILITY(U,$J,358.3,14765,1,4,0)
+4 ;;=4^I69.951
+5 ;;^UTILITY(U,$J,358.3,14765,2)
+6 ;;=^5007561
+7 ;;^UTILITY(U,$J,358.3,14766,0)
+8 ;;=I69.953^^58^707^21
+9 ;;^UTILITY(U,$J,358.3,14766,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,14766,1,3,0)
+12 ;;=3^Hemiplegia after Unsp Crbvasc Dis,Right Nondominant Side
+13 ;;^UTILITY(U,$J,358.3,14766,1,4,0)
+14 ;;=4^I69.953
+15 ;;^UTILITY(U,$J,358.3,14766,2)
+16 ;;=^5007562
+17 ;;^UTILITY(U,$J,358.3,14767,0)
+18 ;;=G81.92^^58^707^22
+19 ;;^UTILITY(U,$J,358.3,14767,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,14767,1,3,0)
+22 ;;=3^Hemiplegia,Unspec Affecting Left Dominant Side
+23 ;;^UTILITY(U,$J,358.3,14767,1,4,0)
+24 ;;=4^G81.92
+25 ;;^UTILITY(U,$J,358.3,14767,2)
+26 ;;=^5004122
+27 ;;^UTILITY(U,$J,358.3,14768,0)
+28 ;;=G81.94^^58^707^23
+29 ;;^UTILITY(U,$J,358.3,14768,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,14768,1,3,0)
+32 ;;=3^Hemiplegia,Unspec Affecting Left Nondominant Side
+33 ;;^UTILITY(U,$J,358.3,14768,1,4,0)
+34 ;;=4^G81.94
+35 ;;^UTILITY(U,$J,358.3,14768,2)
+36 ;;=^5004124
+37 ;;^UTILITY(U,$J,358.3,14769,0)
+38 ;;=G81.91^^58^707^24
+39 ;;^UTILITY(U,$J,358.3,14769,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,14769,1,3,0)
+42 ;;=3^Hemiplegia,Unspec Affecting Right Dominant Side
+43 ;;^UTILITY(U,$J,358.3,14769,1,4,0)
+44 ;;=4^G81.91
+45 ;;^UTILITY(U,$J,358.3,14769,2)
+46 ;;=^5004121
+47 ;;^UTILITY(U,$J,358.3,14770,0)
+48 ;;=G81.93^^58^707^25
+49 ;;^UTILITY(U,$J,358.3,14770,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,14770,1,3,0)
+52 ;;=3^Hemiplegia,Unspec Affecting Right Nondominant Side
+53 ;;^UTILITY(U,$J,358.3,14770,1,4,0)
+54 ;;=4^G81.93
+55 ;;^UTILITY(U,$J,358.3,14770,2)
+56 ;;=^5004123
+57 ;;^UTILITY(U,$J,358.3,14771,0)
+58 ;;=I69.942^^58^707^42
+59 ;;^UTILITY(U,$J,358.3,14771,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,14771,1,3,0)
+62 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Dominant Side
+63 ;;^UTILITY(U,$J,358.3,14771,1,4,0)
+64 ;;=4^I69.942
+65 ;;^UTILITY(U,$J,358.3,14771,2)
+66 ;;=^5133582
+67 ;;^UTILITY(U,$J,358.3,14772,0)
+68 ;;=I69.944^^58^707^43
+69 ;;^UTILITY(U,$J,358.3,14772,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,14772,1,3,0)
+72 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Left Nondominant Side
+73 ;;^UTILITY(U,$J,358.3,14772,1,4,0)
+74 ;;=4^I69.944
+75 ;;^UTILITY(U,$J,358.3,14772,2)
+76 ;;=^5133585
+77 ;;^UTILITY(U,$J,358.3,14773,0)
+78 ;;=I69.941^^58^707^44
+79 ;;^UTILITY(U,$J,358.3,14773,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,14773,1,3,0)
+82 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Dominant Side
+83 ;;^UTILITY(U,$J,358.3,14773,1,4,0)
+84 ;;=4^I69.941
+85 ;;^UTILITY(U,$J,358.3,14773,2)
+86 ;;=^5133581
+87 ;;^UTILITY(U,$J,358.3,14774,0)
+88 ;;=I69.943^^58^707^45
+89 ;;^UTILITY(U,$J,358.3,14774,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,14774,1,3,0)
+92 ;;=3^Monoplg LL after Unsp Crbvasc Dis,Right Nondominant Side
+93 ;;^UTILITY(U,$J,358.3,14774,1,4,0)
+94 ;;=4^I69.943
+95 ;;^UTILITY(U,$J,358.3,14774,2)
+96 ;;=^5133584
+97 ;;^UTILITY(U,$J,358.3,14775,0)
+98 ;;=G35.^^58^707^46
+99 ;;^UTILITY(U,$J,358.3,14775,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,14775,1,3,0)
+102 ;;=3^Multiple sclerosis
+103 ;;^UTILITY(U,$J,358.3,14775,1,4,0)
+104 ;;=4^G35.
+105 ;;^UTILITY(U,$J,358.3,14775,2)
+106 ;;=^79761
+107 ;;^UTILITY(U,$J,358.3,14776,0)
+108 ;;=G20.^^58^707^47
+109 ;;^UTILITY(U,$J,358.3,14776,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,14776,1,3,0)
+112 ;;=3^Parkinson's disease
+113 ;;^UTILITY(U,$J,358.3,14776,1,4,0)
+114 ;;=4^G20.
+115 ;;^UTILITY(U,$J,358.3,14776,2)
+116 ;;=^5003770
+117 ;;^UTILITY(U,$J,358.3,14777,0)
+118 ;;=R56.9^^58^707^6
